SCHEMBL4596470

SCHEMBL4596470

CCOC(=O)C1Cc2cc(-c3ccc(C(F)(F)F)cc3)ccc2NC1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 1/20 0.49
KDM4E B2RXH2 4/20 0.43
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
GAA P10253 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
HPGD P15428 1/20 0.43
HSD17B10 Q99714 1/20 0.43
LMNA P02545 1/20 0.42
RAB9A P51151 1/20 0.41
TDP2 O95551 1/20 0.40
DGAT1 O75907 1/20 0.40
GPBAR1 Q8TDU6 1/20 0.38
TRPC3 Q13507 1/20 0.37
TRPC7 Q9HCX4 1/20 0.37
HTT P42858 1/20 0.37
P2RY14 Q15391 1/20 0.36
TSHR P16473 1/20 0.36
HSP90AA1 P07900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4594888 0.83 KIF11 (0.56) KIF11MEN1KMT2ATDP2DGAT1
SCHEMBL4596412 0.82 KIF11 (0.55) KIF11MEN1KMT2ATDP2P2RY14
SCHEMBL4887887 0.82 KIF11 (0.55) KIF11MEN1KMT2ATDP2CHRNB2
SCHEMBL4596418 0.80 KIF11 (0.55) KIF11MEN1KMT2ATDP2P2RY14
SCHEMBL7824596 0.78 LMNA (0.53) KDM4EMAPTALDH1A1GAAMEN1
SCHEMBL7945190 0.78 ALDH1A1 (0.48) KDM4EMAPTALDH1A1GAAMEN1
SCHEMBL4596144 0.77 KIF11 (0.60) KIF11GAAMEN1KMT2ATDP2
SCHEMBL3467348 0.77 KIF11 (0.41) KIF11MAPTGPBAR1TSHR
SCHEMBL4891219 0.76 KIF11 (0.56) KIF11MEN1KMT2ATDP2P2RY14
SCHEMBL3467771 0.76 KIF11 (0.48) KIF11KMT2ATDP2DGAT1P2RY14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080176830-A1 Compounds, Compositions, and Methods ADAMS NICHOLAS D 2008-07-24 US disclosed
EP-1874753-A2 COMPOUNDS, COMPOSITIONS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2008-01-09 EP disclosed
WO-2006113432-A2 COMPOUNDS, COMPOSITIONS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2006-10-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176830-A1 Compounds, Compositions, and Methods ALPP, PCNA, MKI67 KIF11 562/4885KDM4E 1780/4885MAPT 2954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.